APAC Healthcare Robotics Market

APAC Healthcare Robotics Market Size (2022 to 2027)

The size of the Asia-Pacific healthcare robotics market is forecasted to be growing at a CAGR of 19.68% from 2022 to 2027.

A few of the significant drivers accelerating the market growth in the APAC region is the growing population. Indeed, the region's technological development in health is quite low compared to other parts of the world. In addition to this, the development of new technologies and the awareness of their benefits and use are not evenly distributed; they are mainly present in urban areas. This puts the regional market in a kind of untapped potential, offering plenty of opportunities for investors. Governments are trying to move forward in this regard by introducing various plans and programs.

The growing aging population is driving the demand for healthcare robotics in countries like China and Japan. In addition, the increased application of robotics in various industries, such as entertainment, education, and healthcare, further complements the growth of this market. Robots allow hospitals to automate processes, manufacture high-quality products in large quantities, and increase services while reducing costs and wasting resources. With the ever-increasing advancements in technology, robotics is used in many applications, including pharmacy, telesurgery, physiotherapy, etc.

Technological advancements, including robotic nurses, cloud robotics, and biomimetic, offer plenty of growth opportunities in the market.

The introduction of the Goods and Services Tax (GST) in India has made the healthcare sector difficult as the costs of basic healthcare facilities, such as renting hospital rooms, have increased. In addition, the price of various types of treatment has increased significantly. This will discourage people from participating in robotic surgeries, which are generally more expensive than conventional surgeries. Poor distribution of sanitation facilities in small pockets is also a threat to the market as the lack of transport and logistics infrastructure will dramatically increase treatment costs in poorly connected areas.

Impact of COVID-19 on the APAC healthcare robotics market:

The COVID-19 outbreak will only lead to the adoption of healthcare robotics to perform various tasks, such as contactless delivery operations, disinfection, drug and food delivery, and assistance border controls. Therefore, the market is expected to experience several deployment cases, especially in the healthcare sector. In addition, robots play a crucial role in the fight against the SARS-CoV-2 coronavirus. For example, according to the IFR, Chinese hospitals have ordered more than 2,500 UVD disinfection robots from Danish manufacturer Blue Ocean Robotics. These robots move autonomously around patient rooms and cover all critical surfaces with the right amount of UV-C light to kill viruses.

This research report on the APAC healthcare robotics market has been segmented and sub-segmented based on the following categories:

By Type:

• Surgical
• Non-Surgical
  • Hospital Logistics Robots
  • Rehabilitation Robots
  • Telepresence Robots
  • Radiotherapy Robots
  • Others

By Product:

• Da Vinci
• Mako System
• Sensei X Robotics System
• The CorPath System
• CyberKnife
• Others

By Application:

• General Surgery
• Gynecology
• Urologic Surgery
• Colorectal Surgery
• Orthopedic
• Others

By End User:

• Hospitals and Clinics
• Rehabilitation Centers
• Others

By Country:

• India
• China
• Japan
• South Korea
• Australia
• New Zealand
• Thailand
• Malaysia
• Vietnam
• Philippines
• Indonesia
• Singapore
• Rest of APAC

Geographically, China, Japan, and India are three major countries that have significantly contributed to the growth of healthcare robotics in the APAC region. More and more startups are coming together to offer higher precision systems for surgery and treatment. This, along with an increase in public spending on healthcare infrastructure, are some of the major reasons that have led to the growth of the APAC robotics market in the APAC region. In addition, financial services companies in Asia are looking to rationalize costs to increase dividends for shareholders, maintain profitability and have a new tool that also attracts customers.

The growth of the region can be attributed to increasing investments in infrastructure development in the healthcare segment. In addition to this, more activities and funding for research and development activities are likely to assist in developing the market for visually impaired products and services in the APAC region. Furthermore, the Chinese government has ambitious plans for China’s robotics industry. The government has included the robotics industry and artificial intelligence and automation as one of the priority sectors for high-level development to stimulate the transformation and graduation of the manufacturing industry. This dynamic is expected to increase the APAC market share of healthcare robotics made in China.

KEY MARKET PLAYERS:

Accuray Inc., Aethon, Inc., Ekso Bionics Holdings Inc., Hansen Medical Inc., Intuitive Surgical Inc., Johnson & Johnson, Medrobotics Corporation, Microbot Medical, Inc., Rewalk Robotics, Smith & Nephew plc, Stryker Corporation, Titan Medical Inc., TransEnterix, Inc., Varian Medical Systems Inc., and Zimmer Biomet are a few of the notable companies in the APAC healthcare robotics market.